2023
DOI: 10.1007/s11912-023-01441-1
|View full text |Cite
|
Sign up to set email alerts
|

Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets

Marc El Beaino,
Syed T. Hoda,
Ahmed J. Eldeib
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 93 publications
0
0
0
Order By: Relevance
“…By definition, peripheral CSs are always associated with an extraosseous component; in dedifferentiated CS, the tumor presents as a low-grade, cartilaginous tumor juxtaposed to a generally high-grade, mesenchymal, non-cartilaginous component. In dedifferentiated CS, the high-grade non-cartilaginous component is thought to be more responsible for the diminished survival [27][28][29][30][31].…”
Section: Discussionmentioning
confidence: 99%
“…By definition, peripheral CSs are always associated with an extraosseous component; in dedifferentiated CS, the tumor presents as a low-grade, cartilaginous tumor juxtaposed to a generally high-grade, mesenchymal, non-cartilaginous component. In dedifferentiated CS, the high-grade non-cartilaginous component is thought to be more responsible for the diminished survival [27][28][29][30][31].…”
Section: Discussionmentioning
confidence: 99%
“…Dedifferentiation can occur either initially or during a local recurrence of a previously treated low-grade chondrosarcoma. Pain is the most common presenting symptom in the majority of cases [5].…”
Section: Discussionmentioning
confidence: 99%